Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.180
-0.060 (-4.84%)
At close: Sep 4, 2026, 4:00 PM EDT
1.200
+0.020 (1.69%)
After-hours: Sep 4, 2026, 7:57 PM EDT
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $19.67 million as of September 4, 2026. Its market cap has increased by 75.66% in one year.
Market Cap
19.67M
Enterprise Value
8.34M
1-Year Change
75.66%
Ranking
Category
Stock Price
$1.18
ChartMarket Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $19.67M, a decrease of -57.04%. That is a compound annual growth rate of -8.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 19.70M | -20.56% |
| Dec 31, 2025 | 24.80M | -10.79% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
| Nov 8, 2016 | 45.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 22.35M |
| Cerenome | 22.31M |
| Palatin Technologies | 22.21M |
| Enlivex | 21.86M |
| Lexaria Bioscience | 21.82M |
| Longeveron | 21.62M |
| Cyclerion Therapeutics | 20.83M |
| Neuphoria Therapeutics | 20.27M |